HEALTH

NEW YORK With more than 2,000 nominations from across the country, L'Oreal Paris has selected the 2010 Women of Worth honorees and granted them $5,000 for their charitable causes and donated $5,000 in their names to the Ovarian Cancer Research Fund, L'Oreal Paris' primary philanthropic partner.

NEW YORK Loss of patent protection for branded drugs and subsequent competition from generics could save the U.S. healthcare system $70 billion or more over the next four years, according to published reports.

Reuters reported IMS Health SVP Murray Aitken as saying at the Reuters Health Summit that generics also would increase their dominance in terms of prescriptions dispensed, increasing from 77% during the first half of this year to perhaps 85% by 2014.

AKRON, Ohio Hygenic/Performance Health on Tuesday announced its Perform pain-reliever brand will be the official external analgesic for the 2010-2011 Rock ‘n’ Roll Marathon Series.

WASHINGTON The Consumer Healthcare Products Association recently relaunched its OTCsafety.org site, featuring new resources, content and expert commentaries, as well as a Spanish-language version, the association announced through its newsletter last week.

ST. PAUL, Minn. 3M Skin and Wound Care has announced the relaunch of the 3M Cavilon professional skin care line, a range of products to help prevent skin damage from moisture, friction and adhesive trauma, following research and surveys of caregivers and clinicians.

The revamped line has new, innovative packaging to easily identify the right product for a specific need.

NEW YORK While many consumers claim to have adjusted their diets to include more healthy foods and beverages, new data suggested that there may be a disparity between what is considered "good" by consumers and by experts.

Anew poll by Harris Interactive, conducted between Sept. 14 and 20 among 2,620 adults, found that the majority of all adults claimed that they:

SAN DIEGO Two drug makers conducting a late-stage clinical trial of a drug for treating overweight and obese patients said the drug produced significant weight loss in patients with Type 2 diabetes.

Arena Pharmaceuticals and Eisai reported results of the one-year “BLOOM-DM” phase-3 trial of the drug lorcaserin, showing that a significant number of patients lost 5% to 10% of their weight by the end of the trial. Patients taking the drug also showed improvements in blood sugar levels, compared with those taking placebo.

CLIFFSIDE PARK, N.J. The U.S. Patent and Trademark Office has granted a patent to the privately owned company Pop Test for a means for diabetics to measure their glucose levels without drawing blood, Pop Test said Tuesday.

The company said it is conducting clinical trials on a glucose test that uses saliva to allow Type 1 and Type 2 diabetes patients to monitor blood glucose, and can detect abnormally low and abnormally high blood sugar levels.